Category: investigation

Medical Device Failures Brought To Light Now Bolster Lawsuits And Research

Millions of injuries and malfunctions once funneled into a hidden Food and Drug Administration database are now available.

Medical Device Failures Brought To Light Now Bolster Lawsuits And Research

Millions of injuries and malfunctions once funneled into a hidden Food and Drug Administration database are now available.

UVA Doctors Decry Aggressive Billing Practices By Their Own Hospital

In the wake of a Kaiser Health News investigation, doctors want the University of Virginia’s health system to stop suing its patients over unpaid bills.

FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns

The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors.

As UVA Scales Back Lawsuits, Pain For Past Patients Persists

Patients were thrilled last month when UVA announced it would scale back lawsuits and provide more financial assistance, but the excitement has waned.

Sen. Grassley Questions UVA Health On Findings From KHN Investigation

A letter from the Senate Finance Committee Chairman questions the University of Virginia Health System about its financial assistance policies, billing practices and its prices.

Sen. Grassley Questions UVA Health On Findings From KHN Investigation

A letter from the Senate Finance Committee Chairman questions the University of Virginia Health System about its financial assistance policies, billing practices and its prices.

Must-Reads Of The Week (Some Flying Below The Radar)

Executive editor Damon Darlin takes a spin as host of “The Friday Breeze,” whirling through a week of health care news so you don’t have to.

Death By A Thousand Clicks

The U.S. government claimed that turning American medical charts into electronic records would make health care better, safer and cheaper. Ten years and $36 billion later, the system is an unholy mess. Inside a digital revolution gone wrong.

Drugmakers Funnel Millions To Lawmakers; A Few Dozen Get $100,000-Plus

Drugmakers’ contributions to lawmakers have peaked as surging drug prices emerge as a hot-button political issue. In the past decade, Congress has received nearly $79 million from 68 pharma PACs, run by employees of companies that make drugs treating everything from cancer to erectile dysfunction.